152 related articles for article (PubMed ID: 32099528)
1. Caveolin-2 is regulated by BRD4 and contributes to cell growth in pancreatic cancer.
Jiao F; Han T; Yuan C; Liang Y; Cui J; Zhuo M; Wang L
Cancer Cell Int; 2020; 20():55. PubMed ID: 32099528
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of BRD4 in Gastric Cancer and its Clinical Significance as a Novel Therapeutic Target.
Zhang M; Huang H; Wei M; Sun M; Deng G; Hu S; Wang H; Gong Y
Curr Cancer Drug Targets; 2024; 24(2):167-177. PubMed ID: 37282642
[TBL] [Abstract][Full Text] [Related]
3. BET inhibitor suppresses melanoma progression
Deng G; Zeng F; Su J; Zhao S; Hu R; Zhu W; Hu S; Chen X; Yin M
Theranostics; 2020; 10(25):11428-11443. PubMed ID: 33052224
[No Abstract] [Full Text] [Related]
4. circCELSR1 facilitates ovarian cancer proliferation and metastasis by sponging miR-598 to activate BRD4 signals.
Zeng XY; Yuan J; Wang C; Zeng D; Yong JH; Jiang XY; Lan H; Xiao SS
Mol Med; 2020 Jul; 26(1):70. PubMed ID: 32640974
[TBL] [Abstract][Full Text] [Related]
5. Targeting BRD4 proteins suppresses the growth of NSCLC through downregulation of eIF4E expression.
Gao Z; Yuan T; Zhou X; Ni P; Sun G; Li P; Cheng Z; Wang X
Cancer Biol Ther; 2018 May; 19(5):407-415. PubMed ID: 29333921
[TBL] [Abstract][Full Text] [Related]
6. PES1 promotes BET inhibitors resistance and cells proliferation through increasing c-Myc expression in pancreatic cancer.
Jin X; Fang R; Fan P; Zeng L; Zhang B; Lu X; Liu T
J Exp Clin Cancer Res; 2019 Nov; 38(1):463. PubMed ID: 31718704
[TBL] [Abstract][Full Text] [Related]
7. Circ_0000376 downregulation inhibits the progression of non-small cell lung cancer by mediating the miR-488-3p/BRD4 axis and the PI3K/PKB signaling pathway.
Yuan H; Wu H; Cheng J; Xiong J
Histol Histopathol; 2021 Dec; 36(12):1309-1324. PubMed ID: 34730838
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA circ_0074027 indicates a poor prognosis for NSCLC patients and modulates cell proliferation, apoptosis, and invasion via miR-185-3p mediated BRD4/MADD activation.
Gao P; Wang Z; Hu Z; Jiao X; Yao Y
J Cell Biochem; 2020 Mar; 121(3):2632-2642. PubMed ID: 31680319
[TBL] [Abstract][Full Text] [Related]
9. FBP1 binds to the bromodomain of BRD4 to inhibit pancreatic cancer progression.
Yang C; Zhu S; Yang H; Fan P; Meng Z; Zhao J; Zhang K; Jin X
Am J Cancer Res; 2020; 10(2):523-535. PubMed ID: 32195024
[TBL] [Abstract][Full Text] [Related]
10. ARV-825 Showed Antitumor Activity against BRD4-NUT Fusion Protein by Targeting the BRD4.
Yang L; Jing Y; Xia X; Yin X
J Oncol; 2023; 2023():9904143. PubMed ID: 38130463
[TBL] [Abstract][Full Text] [Related]
11. The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation.
Pastori C; Kapranov P; Penas C; Peschansky V; Volmar CH; Sarkaria JN; Bregy A; Komotar R; St Laurent G; Ayad NG; Wahlestedt C
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8326-31. PubMed ID: 26111795
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression.
Han Q; Li J; Xiong J; Song Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):151. PubMed ID: 32771045
[TBL] [Abstract][Full Text] [Related]
13. Long Noncoding RNA H19 Promotes Tumorigenesis of Multiple Myeloma by Activating BRD4 Signaling by Targeting MicroRNA 152-3p.
Zheng JF; Guo NH; Zi FM; Cheng J
Mol Cell Biol; 2020 Jan; 40(3):. PubMed ID: 31712391
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
15. miR-573 suppresses pancreatic cancer cell proliferation, migration, and invasion through targeting TSPAN1.
Wang L; Gao P; Yuan P; Zhou P; Fan H; Lin X; Yuan X; Zhu M; Fan X; Lu Y; Wang Z
Strahlenther Onkol; 2021 May; 197(5):438-448. PubMed ID: 33320287
[TBL] [Abstract][Full Text] [Related]
16. BRD4 PROTAC degrader ARV-825 inhibits T-cell acute lymphoblastic leukemia by targeting 'Undruggable' Myc-pathway genes.
Wu S; Jiang Y; Hong Y; Chu X; Zhang Z; Tao Y; Fan Z; Bai Z; Li X; Chen Y; Li Z; Ding X; Lv H; Du X; Lim SL; Zhang Y; Huang S; Lu J; Pan J; Hu S
Cancer Cell Int; 2021 Apr; 21(1):230. PubMed ID: 33888130
[TBL] [Abstract][Full Text] [Related]
17. Interfering with bromodomain epigenome readers as therapeutic option in mucoepidermoid carcinoma.
Markman RL; Webber LP; Nascimento Filho CHV; Reis LA; Vargas PA; Lopes MA; Zanella V; Martins MD; Squarize CH; Castilho RM
Cell Oncol (Dordr); 2019 Apr; 42(2):143-155. PubMed ID: 30539410
[TBL] [Abstract][Full Text] [Related]
18. NR5A2 transcriptional activation by BRD4 promotes pancreatic cancer progression by upregulating GDF15.
Guo F; Zhou Y; Guo H; Ren D; Jin X; Wu H
Cell Death Discov; 2021 Apr; 7(1):78. PubMed ID: 33850096
[TBL] [Abstract][Full Text] [Related]
19. B7-H3 is regulated by BRD4 and promotes TLR4 expression in pancreatic ductal adenocarcinoma.
Zhao J; Meng Z; Xie C; Yang C; Liu Z; Wu S; Wang B; Fan P; Jin X; Wu H
Int J Biochem Cell Biol; 2019 Mar; 108():84-91. PubMed ID: 30664982
[TBL] [Abstract][Full Text] [Related]
20. BET bromodomain inhibitors block growth of pancreatic cancer cells in three-dimensional collagen.
Sahai V; Kumar K; Knab LM; Chow CR; Raza SS; Bentrem DJ; Ebine K; Munshi HG
Mol Cancer Ther; 2014 Jul; 13(7):1907-17. PubMed ID: 24807963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
